WGS
GeneDx Holdings Corp.
$146.55
+$12.46(+9.29%)
51
Overall
20
Value
83
Tech
--
Quality
Market Cap
$4.15B
Volume
768.86K
52W Range
$55.17 - $147.71
Target Price
$157.88
Company Overview
| Mkt Cap | $4.15B | Price | $146.55 |
| Volume | 768.86K | Change | +9.29% |
| P/E Ratio | -79.3 | Open | $134.24 |
| Revenue | $305.4M | Prev Close | $134.09 |
| Net Income | $-52.3M | 52W Range | $55.17 - $147.71 |
| Div Yield | N/A | Target | $157.88 |
| Overall | 51 | Value | 20 |
| Quality | -- | Technical | 83 |
No chart data available
About GeneDx Holdings Corp.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company is headquartered in Stamford, Connecticut.
Latest News
New Buy Rating for SS&C Technologies Holdings (SSNC), the Technology Giant
TipRanks Auto-Generated Intelligence Newsdesk•24 days ago
GeneDx Reports Strong Q3 2025 Financial Growth
TipRanks Auto-Generated Newsdesk•a month ago
SS&C Technologies Holdings (SSNC): New Buy Recommendation for This Technology Giant
TipRanks Auto-Generated Intelligence Newsdesk•a month ago
Canaccord Genuity Sticks to Its Buy Rating for GeneDx Holdings (WGS)
TipRanks Auto-Generated Intelligence Newsdesk•a month ago
GeneDx Holdings (WGS) Gets a Buy from Craig-Hallum
TipRanks Auto-Generated Intelligence Newsdesk•a month ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | WGS | $146.55 | +9.3% | 768.86K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |